Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1998-10-20
2000-10-31
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
4284022, 514824, A61K 9127, A61K 9133
Patent
active
061398713
ABSTRACT:
The present invention provides compositions and methods for treating atherosclerosis. The compositions comprise unilamellar liposomes having an average diameter of 100-150 nanometers. Methods for treating atherosclerosis employing the compositions of the present invention are also provided.
REFERENCES:
patent: 4186183 (1980-01-01), Steck et al.
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4774085 (1988-09-01), Fidler
patent: 4812314 (1989-03-01), Barenholz
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5204112 (1993-04-01), Hope et al.
patent: 5231090 (1993-07-01), Hsia
patent: 5252263 (1993-10-01), Hope et al.
patent: 5376452 (1994-12-01), Hope et al.
patent: 5736157 (1998-04-01), Williams
patent: 5746223 (1998-05-01), Williams
patent: 5843474 (1998-12-01), Williams
patent: 5858400 (1999-01-01), Williams
Williams BBA 875, p. 189, 1986.
Williams Perspectives in Biology & Media 27, p. 417, 1984.
Liu BBA 1022, p. 348, (1990).
Adams, et al., "Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins," J. Pathol Bacteriol 94:777-87 (1967).
Altman, et al., "Phospholipids in experimental atherosclerosis," Arzneim Forsch 24:11-16 (1974).
Aviram, et al., "Intralipid infusion abolishes ability of human serum to cholesterol-load cultured macrophages," Atherosclerosis 9:67-75 (1989).
Aviram, et al., "Macrophage cholesterol removal by triglyceride-phospholipid emulsions," Biochem Biophys Res Commun 155:709-713 (1988).
Bally, et al., "Novel procedures for generating and loading liposomal systems," in: Liposomes as drug carriers: recent trends and progress (Gregoriadis G., ed.), pp. 841-853, John Wiley & Sons Ltd.: Chichester, England, 1988.
Bialecki, et al., "Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells," J. Clin Invest 88:1894-1900 (1991).
Blaton, et al., "The human plasma lipids and lipoproteins under influence of EPL-therapy," in: Phosphatidylcholine (Peeters, H., ed.), pp. 125-132, Springer-Verlag: Berlin, 1976.
Bligh, et al., "A Rapid Method of Total Lipid Extraction and Purification," Can. J. Biochem. Physiol. 37:911-917 (1959).
Bloomfield, "Quasi-Elastic Light Scattering Applications in Biochemistry and Biology," Ann. Rev. Biophys. Bioeng. 10:421-450 (1981).
Byers, et al., "Effect of infusions of phosphatides upon the atherosclerosis aorta in situ and as an ocular aortic implant," J. Lipid Res 1:343-349 (1960).
Campanacci, et al., "Response to plasma lipid fractions to the administration of exogenous phospholipids", Arxneimittelforschung 25:1306-1308 (1975).
Chisolm, "Antioxidants and Atherosclerosis: A Current Assessment," Clin. Cardiol., 14:25-30 (1991).
Ciammaichella, et al., "La fosfatidicolin polinsatura (EPL). nel trattamento delle affezioni atersclerotiche cerebrali e degli arti inferiori," Clin Ter 74:55-62 (1975).
Constantinides et al., "Production of Advanced Cholesterol Atherosclerosis in the Rabbit," Arch. Pathol. 70:81-02 (1961).
Deamer, et al., "Large Volume Liposomes by an Ether Vaporization Method," Biochim. Biophys. Acta 443:629-634 (1976).
Ellens, et al. "In vivo fate of large unilamellar sphigomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats," Biochem Biophys Acta 674:10-18 (1981).
Fiske, et al., "The Colorimetric Determination of Phosphorus," J. Biol. Chem. 66:375-400 (1925).
Fraley et al., "Entrapment of a bacterial plasmid in phospholipid vesicles: Potential for gene transfer," Proc. Natl. Acad. Sci. USA 76:3348-3352 (1979).
Friedman, et al., "Resolution of aortic atherosclerosis infiltration in the rabbit by phosphatide infusion," Proc. Soc Exp Biol Med 95:586-588 (1957).
Gregoriadis, et al., "Liposomes In Vivo: A Relationship Between Stability and Clearance?," in: Targeting of Drugs with Synthetic Systems (Gregoriadis, et al., eds.), pp. 183-192, Plenum Press: New York, 1985.
Gwynne, "HDL and Atherosclerosis: An Update," Clin. Cardiol. 14:17-24 (1991).
Holman, et al., "Technics for Studying Atherosclerosis Lesions," Lab., Invest. 7:42-47 (1958).
Hope, et al., "Generation of Multilamellar and Unlilamellar Phospholipid Vesicles," Chem. Phys. Lipids 40:89-107 (1986).
Hope, et al., "Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential," Biochim. Biophys. Acta 812:55-65 (1985).
Howard, et al., "Atherosclerosis induced in hypercholesterolemic baboons by immunological injury; and the effects of intravenous polyunsaturated phosphatidyl choline," Atherosclerosis 14;17-29 (1971).
Krack, et al., "Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients," Perit Dial Int 12:359-364 (1992).
Mauk, et al., "Stability of lipid vesicles in tissues of the mouse: a gamma-ray perturbed angular correlation study," Proc Natl Acad Sci (USA) 76:765-769 (1979).
Maurukas, J., et al., "Treatment of experimental atherosclerosis in the rabbit with L, D. alpha (dimyristoyl) lecithin," J Lab Clin Med 56:30-37 (1960).
Mayer et al., "Vesicles of variable sizes produced by a rapid extrusion procedure," Biochim. Biophys. Acta 858:161-168 (1986).
Mihail, et al., "The coronary syndrome in two cases of essential familial hypercholesterolemia (the therapeutic effect of polyene-phosphatidyl-choline)," Rev Roum Med Intern 10:255-233 (1973).
Miyazaki, A., et al., "Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconsituted high density lipoprotein," J Biol Chem 269:5264-5269 (1994).
Nayar, et al., "Generation of large unilamellar vesicles from long-chain saturated phosphatidylcholines by extrusion technique," Biochim. Biophys. Acta 986:200-206 (1989).
Patelski, et al., "Modification of enzyme activities in experimental atherosclerosis in the rabbit," Atherosclerosis 12:41-53 (1992).
Phillips et al., "Mechanisms and consequences of cellular cholesterol exchange and transfer," Biochim. Biophys. Acta 906:223-276 (1987).
Plane, et al., "Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta," Br J Pharmacol 105:216-222 (1992).
Prior et al., "The Hypercholesteremic Rabbit," Arch. Path. 71:82-94 (1961).
Reynolds, "Rational Therapy of Familial Hypercholesterolemia," Circulation 79:1146-1148 (1989).
Rodrigueza, et al., "The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo," Biochim Biophys Acta 1153:9-19 (1993).
Rose, et al., "Improved procedure for the extraction of lipids from human erthyrocytes," J. Lipid Res. 6:428-431 (1965).
Rosenfeld, et al., "Lipid Composition of Aorta of Watanabe Heritable Hyperlipemic and Comparably Hypercholesterolemic Fat-fed Rabbits," Athereosclerosis 8:338-347 (1988).
Rudell, et al., "Determination of cholesterol using o-phthalaldehyde," J. Lipid Res. 14:364-366 (1973).
Sahni, et al., "Prevention of restonosis by lovastatin after successful coronary angioplasty," Am. Heart J 121:1600-1608 (1991).
Schenk, et al., "Studies on sucrose-palmitate-stearate-containing vesicles encapsulating the cytostatic drug methylglyoxal-bis-guanyl-hydrazone," Pharmzie. 45(10):747-9 (1990).
Scherphof, et al., "Disintegration of Phosphatidylcholine Liposomes in Plasma as a Result of Interaction with High-Density Lipoproteins," Biochim. Biophys. Acta 542:296-307 (1978).
Schmidt, et al., "High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase," Biochem Biophys Res Commun 182:302-308 (1992).
Schroeder, et al., "Membrane Cholesterol Dynamics: Cholesterol Domains and Kinetic Pools," Exp. Biol. Med. 196:235-252 (1991).
Schumaker et al., "Sequential Flotation Ultracentrifugation," Methods Enzy
Hope Michael J.
Rodrigueza Wendi
Kishore Gollamudi S.
The University of British Columbia
LandOfFree
Liposome compositions and methods for the treatment of atheroscl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposome compositions and methods for the treatment of atheroscl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome compositions and methods for the treatment of atheroscl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2048195